Pegfilgrastim Market - Global Professional Analysis and Forecast to 2026

Oct 17, 2019 | 151 PAGES | REPORT CODE: CMM215771

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The worldwide Pegfilgrastim market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period.

This report presents the market size and development trends by detailing the Pegfilgrastim market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pegfilgrastim market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pegfilgrastim industry and will help you to build a panoramic view of the industrial development.

Pegfilgrastim Market, By Type:

Powder
Reagent
Other

Pegfilgrastim Market, By Application:

Oncology
Hematological DIsease
Other

Some of the leading players are as follows:

Qilu Pharmaceutical
Hexal
Dong-A Socio Group
Dr. Reddys Laboratories
Novartis
Teva Pharmaceutical Industries Ltd
Merck KGaA
GenSci
Amgen Inc
NCPC
Harbin Pharm
Amoytop Bio
Biocad
SL PHARM
Pfizer
Intas Pharmaceuticals Ltd
Hospira
Chugai Pharm
Kirin kunpeng

Geographically, Major regions are analyzed in details are as follows:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Table of Contents

1 Methodology and Scope

1.1 Market Segmentation & Scope

1.1.1 Technology Type
1.1.2 Product
1.1.3 Application
1.1.4 Regional scope
1.1.5 Estimates and forecast timeline

1.2 Research Methodology
1.3 Information Procurement

1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research

1.4 Information or Data Analysis

1.4.1 Data analysis models

1.5 Market Formulation & Validation
1.6 Model Details

1.6.1 Commodity flow analysis
1.6.2 Volume price analysis

1.7 List of Secondary Sources
1.8 List of Abbreviations

2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook

3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.1.1 Parent market outlook

3.1.2 Ancillary market outlook

3.2 Market Segmentation

3.2.1 Analysis

3.3 Market Dynamics

3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3 Industry opportunities

3.4 Penetration & Growth Prospect Mapping

3.4.1 Penetration & growth prospect mapping analysis

3.5 Business Environment Analysis Tools

3.5.1 Porter's five forces analysis
3.5.2 PESTLE analysis
3.5.3 Major deals & strategic alliances analysis

4 Pegfilgrastim Market: Technology Type Analysis

4.1 Pegfilgrastim Technology Type Market Share Analysis, 2018 & 2026
4.2 Pegfilgrastim Technology Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

4.3.1 Powder
4.3.2 Reagent
4.3.3 Other

5 Pegfilgrastim Market: Product Analysis

5.1 Pegfilgrastim Product Market Share Analysis, 2018 & 2026
5.2 Pegfilgrastim Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pegfilgrastim Market: Application Analysis

6.1 Pegfilgrastim Application Market Share Analysis, 2018 & 2026
6.2 Pegfilgrastim Application Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

6.3.1 Oncology
6.3.2 Hematological DIsease
6.3.3 Other

7 Pegfilgrastim Market: Regional Analysis

7.1 Pegfilgrastim Regional Market Share Analysis, 2018 & 2026
7.2 Pegfilgrastim Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
7.4 List of Players at Regional Level

7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific

7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA

7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East & Africa

8 Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3 Vendor Landscape

8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

9.1 Qilu Pharmaceutical

9.1.1 Qilu Pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis

9.2 Hexal

9.2.1 Hexal Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis

9.3 Dong-A Socio Group

9.3.1 Dong-A Socio Group Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis

9.4 Dr. Reddys Laboratories

9.4.1 Dr. Reddys Laboratories Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis

9.5 Novartis

9.5.1 Novartis Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis

9.6 Teva Pharmaceutical Industries Ltd

9.6.1 Teva Pharmaceutical Industries Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis

9.7 Merck KGaA

9.7.1 Merck KGaA Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis

9.8 GenSci

9.8.1 GenSci Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis

9.9 Amgen Inc

9.9.1 Amgen Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis

9.10 NCPC

9.10.1 NCPC Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis

9.11 Harbin Pharm

9.11.1 Harbin Pharm Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis

9.12 Amoytop Bio

9.12.1 Amoytop Bio Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis

9.13 Biocad

9.13.1 Biocad Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis

9.14 SL PHARM

9.14.1 SL PHARM Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis

9.15 Pfizer

9.15.1 Pfizer Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis

9.16 Intas Pharmaceuticals Ltd

9.16.1 Intas Pharmaceuticals Ltd Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis

9.17 Hospira

9.17.1 Hospira Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis

9.18 Chugai Pharm

9.18.1 Chugai Pharm Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis

9.19 Kirin kunpeng

9.19.1 Kirin kunpeng Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis

The List of Tables and Figures (Totals 106 Figures and 157 Tables)

Figure Powder Pegfilgrastim market, 2015 - 2026 (USD Million)
Figure Reagent Pegfilgrastim market, 2015 - 2026 (USD Million)
Figure Other Pegfilgrastim market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Hematological DIsease market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
Table List of players in North America
Table List of players in Europe
Table List of players in Asia Pacific
Table SWOT analysis
Table North America Pegfilgrastim market, by country, 2015 - 2026 (USD Million)
Table North America Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table North America Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table North America Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.S. Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table U.S. Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table U.S. Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Canada Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Canada Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Canada Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Europe Pegfilgrastim market, by country, 2015 - 2026 (USD Million)
Table Europe Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Europe Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Europe Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.K. Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table U.K. Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table U.K. Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Germany Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Germany Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Germany Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table France Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table France Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table France Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Italy Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Italy Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Italy Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Spain Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Spain Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Spain Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Asia Pacific Pegfilgrastim market, by country, 2015 - 2026 (USD Million)
Table Asia Pacific Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Asia Pacific Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Asia Pacific Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table China Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table China Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table China Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Japan Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Japan Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Japan Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table India Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table India Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table India Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Latin America Pegfilgrastim market, by country, 2015 - 2026 (USD Million)
Table Latin America Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Latin America Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Latin America Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Brazil Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Brazil Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Brazil Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Mexico Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Mexico Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Mexico Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Argentina Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Argentina Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Argentina Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table MEA Pegfilgrastim market, by country, 2015 - 2026 (USD Million)
Table MEA Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table MEA Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table MEA Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table South Africa Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table South Africa Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table South Africa Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Nigeria Pegfilgrastim market, by type, 2015 - 2026 (USD Million)
Table Nigeria Pegfilgrastim market, by product, 2015 - 2026 (USD Million)
Table Nigeria Pegfilgrastim market, by application, 2015 - 2026 (USD Million)
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Company market position analysis
Table Company Profiles
Table Qilu Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hexal Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dong-A Socio Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dr. Reddys Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck KGaA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GenSci Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NCPC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Harbin Pharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amoytop Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biocad Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SL PHARM Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Intas Pharmaceuticals Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hospira Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chugai Pharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kirin kunpeng Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis

REPORTS

Let’s Pullulate and Expand Your Business

Pegfilgrastim Market - Global Professional Analysis and Forecast to 2026

Report Purchase